Ubiquitin E3 ligase MARCH7 promotes ovarian tumor growth

Jianguo Hu; Ying Meng; Tinghe Yu; Lina Hu; Ming Mao

doi:10.18632/oncotarget.3650

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Ubiquitin E3 ligase MARCH7 promotes ovarian tumor growth

Jianguo Hu, Ying Meng, Tinghe Yu, Lina Hu _ and Ming Mao

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:12174-12187. https://doi.org/10.18632/oncotarget.3650

Metrics: PDF 2241 views | HTML 2916 views | ?

Abstract

Jianguo Hu1, Ying Meng1, Tinghe Yu1, Lina Hu1, Ming Mao1

1 Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China

Correspondence to:

Lina Hu, email:

Keywords: ovarian cancer, MARCH7, NF-Kb, Wnt, β-catenin

Received: October 21, 2014 Accepted: February 28, 2015 Published: March 26, 2015

Abstract

Ubiquitin E3 ligase MARCH7 is involved in T cell proliferation and neuronal development. We found that expression of MARCH7 was higher in ovarian cancer tissues than normal ovarian tissues. Silencing MARCH7 decreased cell proliferation, migration, and invasion. Ectopic expression of MARCH7 increased cell proliferation, migration and invasion. Silencing MARCH7 prevented ovarian cancer growth in mice. Silencing MARCH7 inhibited NFkB and Wnt/β-catenin pathway. In agreement, ectopically expressed MARCH7 activated NFkB and Wnt/β-catenin pathways. Finally, MARCH7 was regulated by miR-101. Thus, MARCH7 is oncogenic and a potential target (oncotarget) for ovarian cancer therapy.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3650

Publication Alerts

Research Papers:

Ubiquitin E3 ligase MARCH7 promotes ovarian tumor growth

Abstract